Umoja Biopharma Closes an Oversubscribed $210 Million Series B
Series B financing co-led by SoftBank Vision Fund 2 and Cormorant Asset Management Financing accelerates development of Umoja’s pipeline of in vivo engineered CAR T...
Tag : medical trials
RNA Medicines Developer Ochre Bio Closes $9.6M Seed Financing
Funding will be used to develop RNA therapies for transplant and chronic liver diseases Ochre Bio has built a deep phenotyping platform to identify novel...
Novel Drug Binders Developer RayzeBio Secures $108 Million
–Total raise of $258 million since company launch in August 2020– RayzeBio, Inc., which is discovering and developing a broad pipeline of innovative targeted radiopharmaceutical...
Alentis Therapeutics Raises USD 67 Million in Series B
Funding to Advance Pipeline of Anti-fibrotic Molecules into the Clinic Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, today announced that it...
TransPerfect Life Sciences Unveils AI-Powered TMF Automation
TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced its...
HiFiBiO Therapeutics Closes $75 Million Series D Financing
Latest funding led by Mirae Asset Financial Group and joined by B Capital Group, Sherpa, and other new investors together with existing investors such as...
Senda Biosciences Announces Closing of $98 Million Series B
Funding to accelerate development of its platform and therapeutic programs Senda Biosciences, a company that is systematically harnessing the powerful molecular interactions that have evolved...
Bright Peak Therapeutics Announces $107 Million Series B
–Proceeds to advance company’s pipeline of next-generation cytokine immunotherapies– –Laura Shawver, Christine Siu join as independent directors– Bright Peak Therapeutics, a biotechnology company developing next-generation...
Kurome Therapeutics Closes $15 Million Series A
Financing Co-led by Medicxi and Affinity Asset Advisors Funding to Advance IRAK1/4 Inhibitor Platform Through IND-Enabling Studies Kurome Therapeutics, a preclinical stage company dedicated to...
AI-Based Clinical Trial Matching Solution, Deep Lens’ Viper Expand
Deep Lens today announced a collaboration that will integrate Deep Lens’ artificial intelligence (AI)-based clinical trial screening and matching solution VIPER™ , into cancer research....